A simple mathematical model for relapsing-remitting multiple sclerosis (RRMS)

被引：10
|
作者：
Elettreby, M. F. [1 ,2 ]
Ahmed, E. [2 ]
机构：
[1] King Khalid Univ, Fac Sci, Math Dept, Abha 9004, Saudi Arabia
[2] Mansoura Univ, Fac Sci, Math Dept, Mansoura 35516, Egypt
来源：
MEDICAL HYPOTHESES | 2020年 / 135卷
关键词：
Multiple sclerosis; Relapse; Recurrence; Autoimmune diseases; Complex system; MATTER VOLUME; LYMPHOCYTES; CYTOKINES; BRAIN; GREY;
D O I：
10.1016/j.mehy.2019.109478
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Multiple sclerosis is one of the most common autoimmune-related neurological disorders affecting the central nervous system. One of its main properties is dissemination of lesions in time and space. Here, we propose a simple mathematical model to describe the stages of disease progression with recurrence. We tried to find the steady states and evaluated their stability to identify the necessary conditions to produce the recurrence. Also, we described the analytical results with some numerical simulations.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients
    Rio, Jordi
    Rovira, Alex
    Tintore, Mar
    Sastre-Garriga, Jaurne
    Castillo, Joaquin
    Auger, Cristina
    Nos, Carlos
    Comabella, Manuel
    Tur, Carmen
    Vidal, Angela
    Montalban, Xavier
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (12) : 1602 - 1608
  • [2] Relapsing-remitting tumefactive multiple sclerosis
    Selkirk, SM
    Shi, J
    MULTIPLE SCLEROSIS, 2005, 11 (06): : 731 - 734
  • [3] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
  • [4] Depression in relapsing-remitting multiple sclerosis
    Mendes, MF
    Tilbery, CP
    Balsimelli, S
    Moreira, MA
    Barao-Cruz, AM
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2003, 61 (3A) : 591 - 595
  • [5] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [6] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Guo, Rui
    Zhang, Fubo
    Zhang, Chao
    Dong, Shuai
    Zhou, Hongyu
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [7] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [8] Correlates and trajectories of relapses in relapsing-remitting multiple sclerosis
    Young, Carolyn A.
    Rog, David J.
    Sharrack, Basil
    Tanasescu, Radu
    Kalra, Seema
    Harrower, Timothy
    Tennant, Alan
    Mills, Roger J.
    NEUROLOGICAL SCIENCES, 2024, 45 (05) : 2181 - 2189
  • [9] Increased Level of Caspase-1 in the Serum of Relapsing-remitting Multiple Sclerosis (RRMS) Patients
    Beheshti, Masoumeh
    Salehi, Zahra
    Abolfazli, Roya
    Shirzad, Hedayatolah
    Izad, Maryam
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2020, 19 (05) : 534 - 538
  • [10] Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple Sclerosis
    Kneider, Maria
    Lisoyskaja, Vera
    Lycke, Jan
    Malmestrom, Clas
    Jakobsen, Johannes K.
    Nerman, E.
    Andersen, Oluf
    NEUROEPIDEMIOLOGY, 2015, 45 (02) : 83 - 89
12345